COVID-19 poses unique challenges for CTEPH. Join our 4/21/20 webinar to learn more:
6:30PM ET myspeakerbureau.com/6vQ6BA Enter program #: BAY0000376; State: New Jersey
8:30PM ET myspeakerbureau.com/1lG6C3 Enter program #: BAY0000377; State: New Jersey
Sunday, July 14th is the deadline to submit your letter of intent for the Pulmonary
Hypertension Accelerated Bayer (PHAB) Awards. Visit PHAB-Awards.com to learn more.
The deadline to submit your letter of intent for the Pulmonary Hypertension Accelerated Bayer
(PHAB) Awards grant program is July 14th. Visit PHAB-Awards.com to learn more.
Bayer is offering the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards. Bayer is
providing up to $1 million in grants over a 2-year period to support clinical research in
pulmonary hypertension with focus on PAH & CTEPH. Visit PHAB-Awards.com to learn more.
Patient has Dyspnea 3 months after anticoagulation therapy for a PE? Learn about what to do next at bit.ly/1KqM0ra #CTEPH #HCP
True or False: A ventilation/perfusion (V/Q) scan showing perfusion defects is sufficient to diagnose #CTEPH bit.ly/1LhsEpj #HCP
As many as 1/25 previously treated PE patients (>3 mos anticoagulation) could develop form of PH called #CTEPH bit.ly/24fYcmI #HCP
#CTEPH is only type of #PH that can be cured with a surgery called pulmonary thromboendarterectomy (PTE) Talk to Dr bit.ly/1KnD7dA
Myth: #PTE surgery has a high mortality rate. Fact: Experienced centers can see mortality rates below 5% #CTEPH bit.ly/1W44im1 #HCP
#CTEPH is a potentially surgically curable form of #PH: up to 1 in 25 w/ a treated blood clot may be at risk. Talk to your Dr bit.ly/r@nd0m
Myth: #pulmonary thromboendarterectomy (PTE) is still an experimental technique in #CTEPH treatment bit.ly/r@nd0m #HCP
Myth: Ill patients can’t have pulmonary thromboendarterectomy surgery, a potentially curative #CTEPH treatment bit.ly/r@nd0m #HCP
Learn more about a type of #PH that is potentially surgically curable. Ask your Dr and click bit.ly/r@nd0m for information about #CTEPH





